These findings also demonstrated that EMP3 may be the candidate gene downstream of CD13 in CDDP-resistant GC cells and Ubenimex stimulation that can induce hypermethylation-mediated transcriptional silencing of EMP3. The gene discussed is ANPEP; the disease is gastric cancer.